Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat
- PMID: 8593442
- DOI: 10.1248/bpb.18.1387
Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat
Abstract
Nattokinase is a new fibrinolytic enzyme which cleaves directly cross-linked fibrin in vitro. In this study, we investigated the thrombolytic effect of nattokinase on a thrombus in the common carotid artery of rat in which the endothelial cells of the vessel wall were injured by acetic acid. When a section of occluded vessel was stained for CD61 antigen by immunofluorescence utilizing a monoclonal antibody, the antigen was localized around the surface of the occluded blood vessels. This result suggests that the occlusive thrombosis was caused by platelet aggregation. In addition, thrombolysis with urokinase (UK; 50000 IU/kg, i.v.) or tissue plasminogen activator (tPA; 13300 IU/kg, i.v.) in our model was observed to restore the blood flow over a 60 min monitoring period. The results indicate that our chemically induced model is useful for screening and evaluating a thrombolytic agent. We evaluated the thrombolytic activity of nattokinase using this model and compared it with fibrino(geno)lytic enzyme, plasmin or elastase. On a molar basis, the recovery of the arterial blood flow with nattokinase, plasmin and elastase were 62.0 +/- 5.3%, 15.8 +/- 0.7% and 0%, respectively. The results indicate that the thrombolytic activity of nattokinase is stronger than that of plasmin or elastase in vivo.
Similar articles
-
Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis.Acta Haematol. 2014;132(2):247-53. doi: 10.1159/000360360. Acta Haematol. 2014. PMID: 24862625
-
[An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].No To Shinkei. 1990 Feb;42(2):193-201. No To Shinkei. 1990. PMID: 2113401 Japanese.
-
Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.J Am Coll Cardiol. 1992 May;19(6):1350-9. doi: 10.1016/0735-1097(92)90344-m. J Am Coll Cardiol. 1992. PMID: 1342779
-
The search for the ideal thrombolytic agent.J Am Coll Cardiol. 1987 Nov;10(5 Suppl B):4B-10B. doi: 10.1016/s0735-1097(87)80421-7. J Am Coll Cardiol. 1987. PMID: 2959714 Review.
-
[Thrombolytic agents].Nihon Rinsho. 2014 Jul;72(7):1254-7. Nihon Rinsho. 2014. PMID: 25163317 Review. Japanese.
Cited by
-
The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.Biochem J. 2022 Aug 31;479(16):1653-1708. doi: 10.1042/BCJ20220154. Biochem J. 2022. PMID: 36043493 Free PMC article. Review.
-
The health effects of soy: A reference guide for health professionals.Front Nutr. 2022 Aug 11;9:970364. doi: 10.3389/fnut.2022.970364. eCollection 2022. Front Nutr. 2022. PMID: 36034914 Free PMC article. Review.
-
Biotechnology, Bioengineering and Applications of Bacillus Nattokinase.Biomolecules. 2022 Jul 13;12(7):980. doi: 10.3390/biom12070980. Biomolecules. 2022. PMID: 35883536 Free PMC article. Review.
-
Bio-inspired microcapsule for targeted antithrombotic drug delivery.RSC Adv. 2018 Jul 31;8(48):27253-27259. doi: 10.1039/c8ra04273j. eCollection 2018 Jul 30. RSC Adv. 2018. PMID: 35539989 Free PMC article.
-
Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications.Pharmaceutics. 2021 Nov 5;13(11):1880. doi: 10.3390/pharmaceutics13111880. Pharmaceutics. 2021. PMID: 34834294 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources